Aurora Cannabis Inc. (ACB)
NASDAQ: ACB · Real-Time Price · USD
5.37
-0.17 (-2.98%)
Aug 14, 2025, 11:38 AM - Market open
Aurora Cannabis Revenue
Aurora Cannabis had revenue of 98.02M CAD in the quarter ending June 30, 2025, with 17.48% growth. This brings the company's revenue in the last twelve months to 357.88M, up 28.58% year-over-year. In the fiscal year ending March 31, 2025, Aurora Cannabis had annual revenue of 343.29M with 27.32% growth.
Revenue (ttm)
357.88M CAD
Revenue Growth
+28.58%
P/S Ratio
1.19
Revenue / Employee
333,533 CAD
Employees
1,073
Market Cap
312.87M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 343.29M | 73.66M | 27.32% |
Mar 31, 2024 | 269.64M | 45.83M | 20.48% |
Mar 31, 2023 | 223.80M | 2.47M | 1.11% |
Jun 30, 2022 | 221.34M | -23.91M | -9.75% |
Jun 30, 2021 | 245.25M | -23.45M | -8.73% |
Jun 30, 2020 | Pro | Pro | Pro |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ACB News
- 1 day ago - Top Canadian Marijuana Stocks If Federal Reform Passes In The USA - MarijuanaStocks
- 2 days ago - Aurora Ignites Global Expansion with Whistler Cannabis Co. Brand Debut in Australia - PRNewsWire
- 5 days ago - Aurora Cannabis: Downgrading On Regulatory Headwinds And Competitive Pressures - Hold - Seeking Alpha
- 5 days ago - Aurora Cannabis Inc. Announces Results of 2025 Annual General and Special Meeting - PRNewsWire
- 7 days ago - Aurora to Participate in Canaccord Genuity 45th Annual Growth Conference - PRNewsWire
- 7 days ago - Aurora Cannabis Inc. (ACB) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Aurora Cannabis Announces Fiscal 2026 First Quarter Results - PRNewsWire
- 15 days ago - Cannabis Stocks Are at a Turning Point: Is Now the Time to Invest? - MarijuanaStocks